iiinova — where your digital self keeps evolving

Benoît Brilland @benoitbrilland.bsky.social · 22/01/2026

Our large kidney transcriptomic dataset of #ANCA #glomerulonephritis is now publicly available (www.ncbi.nlm.nih.gov/geo/query/ac...). Used to describe a strong renal interferon signature and a prognosis signature outperforming current classifications (links below). I hope it will be useful! 🚀

144

Reposted by Benoît Brilland

ASN Publications @asnpublications.bsky.social · 07/11/2025

Featuring this year's #ASNJASN Trainee of the Year's award-winning manuscript: "Identification of Renal Transcripts Associated with Kidney Function and Prognosis in ANCA-Associated Vasculitis" kidney.pub/JASN0779 @benoitbrilland.bsky.social @maineanjoureg.bsky.social

051

Benoît Brilland @benoitbrilland.bsky.social · 07/11/2025

Using kidney transcriptomics, we identified a signature predicting renal survival in #ANCA #vasculitis, outperforming histopathology and opening the way to precision medicine. Thank you @asnpublications.bsky.social for highlighting our work... and for making the article 🔓 OPEN ACCESS 🔓 for 1 month!!

000

Benoît Brilland @benoitbrilland.bsky.social · 07/11/2025

Honored that our work on renal transcriptomics in #ANCA -associated #vasculitis was selected for the #ASNJASN Trainee of the Year award. Very proud to represent the @maineanjoureg.bsky.social and @chuangers.bsky.social !

000

Benoît Brilland @benoitbrilland.bsky.social · 09/09/2025

Using kidney transcriptomics, we identified a robust 12-gene signature predicting renal survival in #ANCA #vasculitis, outperforming histopathology, and opening the way to precision medicine. Thank you for the highlight @asnpublications.bsky.social !

051

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 25/04/2025

Ex vivo #CRISPR-Cas9 knock out PR3 autoantigen in HSPCs prevents PR3-ANCA-driven neutrophil activation while preserving immune function. While aHSCT would still be required, this opens the door to sustained, drug-free remission in PR3 #ANCA #vasculitis! doi.org/10.1016/j.ki... @kidneyint.bsky.social

011

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 01/04/2025

This new study shifts the focus from anti-MPO IgG to IgM in #ANCA -associated #vasculitis. IgM autoantibodies not only trigger potent complement activation but also dominate the autoreactive memory B cell pool—revealing a new pathogenic paradigm. Potential implications ⬇️

111

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 01/04/2025

Targeting endothelial ferroptosis protects kidneys in #ANCA -associated #vasculitis, while systemic inhibition increases inflammation. This is why cell-specific therapies should be prioritised over blanket treatments! @kidneyint.bsky.social doi.org/10.1016/j.ki...

012

Benoît Brilland @benoitbrilland.bsky.social · 29/03/2025

US 🇺🇸 nephrologists, immunologists, pathologists (et al.): there is a place for each of you in France 🇫🇷 … and especially in Angers if you like #vasculitis! www.nature.com/articles/d41...

nature.com

75% of US scientists who answered Nature poll consider leaving

More than 1,600 readers answered our poll; many said they were looking for jobs in Europe and Canada.

051

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 24/03/2025

Kidney transplantation significantly improves survival in #ANCA-associated #vasculitis patients with end-stage kidney disease: 53% lower mortality risk. Our analysis from the french REIN registry ⬇️

021

Benoît Brilland @benoitbrilland.bsky.social · 26/02/2025

Kidney transplantation significantly improves survival in #ANCA-associated #vasculitis patients with end-stage kidney disease: 53% lower mortality risk. Let's improve access to #KidneyTransplant! Read more in our analysis from the french REIN registry doi.org/10.1016/j.ek...

031

Benoît Brilland @benoitbrilland.bsky.social · 31/01/2025

Welcome on Bluesky! @brixsilke.bsky.social @odlerb.bsky.social @thkc.bsky.social @paradise-project.bsky.social. I have included you in the « vasculits lovers » starter pack go.bsky.app/HFADD3c

051

Benoît Brilland @benoitbrilland.bsky.social · 21/01/2025

Next International #Vasculitis Workshop host @anzvasc.bsky.social is now on Bluesky! See key dates below ⬇️

021

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 08/01/2025

PEXIVAS post-hoc: no effect of reduced GC dose on kidney recovery in #ANCA #vasculitis. Faster kidney recovery with PLEX but not sustained beyond 3 months (better for subgroup GFR 15-30?). Real PLEX effect vs convection effect? @kronbichlerlab.bsky.social www.kidney-international.org/article/S008...

041

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 06/01/2025

Infection is the top cause of death in #ANCA -associated #vasculitis, mostly during remission. Death certificates misreport causes, linking EHRs improves accuracy. We need to reduce infection risks through better immunosuppressive therapies www.sciencedirect.com/science/arti...

001

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 17/12/2024

In #ANCA #vasculitis, 27% patients rated their health better or worse (≥ 20 PGA points) than their physicians did. This discordance highlights the need to address patients' perspectives to improve communication, shared decision-making, and care outcomes. pubmed.ncbi.nlm.nih.gov/39671122/

011

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 12/12/2024

First AI-driven model for grading #ANCA -associated #glomerulonephritis lesions achieves 93% accuracy. Grad-CAM heatmaps align with pathologists’ focus, enhancing prognosis reliability. Bonus: the heatmaps look like colorful PET scans of glomeruli! www.kireports.org/article/S246...

164

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 10/12/2024

Infections affect >50% of #ANCA -associated #vasculitis patients, with risk factors including diabetes, ESKD, kidney/lung involvement and treatment (methylprednisolone pulses, CYC, PLEX). Main site: respiratory system. Early risk management is crucial. doi.org/10.1016/j.au...

doi.org

Redirecting

041

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 05/12/2024

Brace yourself, next Vasculitis Workshop is coming! Key dates: ✅ Abstract submission: 28 March - 19 September 2025 ✅ Workshop dates: 21 - 25 February 2026 📍 Melbourne, Australia vasculitis-melbourne2026.com

vasculitis-melbourne2026.com

IVW 2026 | 22nd International Vasculitis Workshop

Join the 22nd International Vasculitis Workshop, a leading event dedicated to advancing research, treatment, and understanding of vasculitis. Connect with global experts, researchers, and practitioner...

022

Reposted by Benoît Brilland

The Conversation France @france.theconversation.com · 21/11/2024

Bonjour, bonjour, The Conversation France arrive sur Bluesky ! Ici, pas de breaking news tapageuses ni de buzz éphémères : on mise sur le fond, avec des articles écrits par des chercheurs et chercheuses qui savent de quoi ils parlent, en collaboration avec notre équipe d'excellents journalistes.

22415124

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 02/12/2024

Results of the TAPIR trial: glucocorticoid discontinuation in GPA #ANCA vasculitis. ▶️ higher number of relapse at 6 months for the discontinuation group ▶️ but driven by minor relapses and by subgroup not treated but Rituximab. Presented by Pr. Peter Merkel #ACR24 (acrabstracts.org/abstract/a-m...)

011

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 26/11/2024

Reduced GC dose in #ANCA vasculitis: @terrierben.bsky.social confirms PEXIVAS results in real life: no difference in death/ESKD. Larger composite criteria [see table] (that may be discussed) in favor of standard GC dose, especially for RTX patients and severe AKI ard.bmj.com/content/earl...

055

Reposted by Benoît Brilland

Maine-Anjou Research Group @maineanjoureg.bsky.social · 24/11/2024

Welcome in @terrierben.bsky.social. The #vasculitis family is growing here on Bluesky!

032

Benoît Brilland @benoitbrilland.bsky.social · 20/11/2024

Moving from Twitter? Looking for #vasculits #glomerulonephritis lovers? Starter pack (work in progress): go.bsky.app/HFADD3c. Reply or DM to be added in the list!

330

Benoît Brilland @benoitbrilland.bsky.social · 18/11/2024

Two recent reviews of #ANCA vasculitis with wonderful graphics, and for the first time I think, #PR3 🔹 and #MPO 🔸 phenotypes considered in parallel but SEPARATELY! A new era with individualized treatment is coming for sure! 🔹 pubmed.ncbi.nlm.nih.gov/38574742/ 🔸 pubmed.ncbi.nlm.nih.gov/38574743/

bit.ly

Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis

Proteinase 3 (PR3)-specific antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of two major ANCA-associated vasculitis variants a…

1106

Reposted by Benoît Brilland

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 17/11/2024

Related: if any of the Rheums are nephro adjacent and are interested in lupus, vasculitis stuff, there’s a GN/Vasculitis starter pack from @benoitbrilland.bsky.social go.bsky.app/HFADD3c Reply or ping him to be added!

151

Benoît Brilland @benoitbrilland.bsky.social · 16/11/2024

Moving from Twitter? Looking for #vasculits #glomerulonephritis lovers? Starter pack (work in progress): go.bsky.app/HFADD3c. Reply or DM to be added in the list!

71710